Short-course adjuvant trastuzumab will increase cure rates in patients with human epidermal growth factor receptor 2-positive breast cancer
-
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
South African Medical Association
2017-08-01
|
Series: | South African Medical Journal |
Subjects: | |
Online Access: | http://www.samj.org.za/index.php/samj/article/view/12028/8195 |